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Abstract
Background: While several studies have identified the anaerobic threshold (AT) through the responses of blood
lactate, ventilation and blood glucose others have suggested the response of the heart rate variability (HRV) as a
method to identify the AT in young healthy individuals. However, the validity of HRV in estimating the lactate
threshold (LT) and ventilatory threshold (VT) for individuals with type 2 diabetes (T2D) has not been investigated
yet.
Aim: To analyze the possibility of identifying the heart rate variability threshold (HRVT) by considering the
responses of parasympathetic indicators during incremental exercise test in type 2 diabetics subjects (T2D) and non
diabetics individuals (ND).
Methods: Nine T2D (55.6 ± 5.7 years, 83.4 ± 26.6 kg, 30.9 ± 5.2 kg.m
2(-1)) and ten ND (50.8 ± 5.1 years, 76.2 ± 14.3
kg, 26.5 ± 3.8 kg.m
2(-1)) underwent to an incremental exercise test (IT) on a cycle ergometer. Heart rate (HR), rate of
perceived exertion (RPE), blood lactate and expired gas concentrations were measured at the end of each stage.
HRVT was identified through the responses of root mean square successive difference between adjacent R-R
intervals (RMSSD) and standard deviation of instantaneous beat-to-beat R-R interval variability (SD1) by considering
the last 60 s of each incremental stage, and were known as HRVT by RMSSD and SD1 (HRVT-RMSSD and HRVT-
SD1), respectively.
Results: No differences were observed within groups for the exercise intensities corresponding to LT, VT, HRVT-
RMSSD and HHVT-SD1. Furthermore, a strong relationship were verified among the studied parameters both for
T2D (r = 0.68 to 0.87) and ND (r = 0.91 to 0.98) and the Bland & Altman technique confirmed the agreement
among them.
Conclusion: The HRVT identification by the proposed autonomic indicators (SD1 and RMSSD) were demonstrated
to be valid to estimate the LT and VT for both T2D and ND.
Introduction
The maximal oxygen consumption (VO2max)a n da n a e -
robic threshold (AT) are parameters that have been
widely considered as hallmarks of aerobic fitness both
for athletes [1], physically active individuals [2] and, in a
minor scale, for special populations such as individuals
with type 2 diabetes (T2D) [3,4].
Regular exercise provides many physiologic benefits,
reduces risk of disease outcomes, and triggers important
psychological gains in healthy and pathological condi-
tions. Moreover, few studies have evaluated the effect of
different exercise intensities on T2D [5]. The AT can be
used in this specific evaluation and has been considered
a gold standard parameter for exercise prescription
including cardiovascular risks groups [3,6].
While several studies have identified the AT through
the responses of blood lactate [2,7,8] ventilation [9] and
blood glucose [7] others have suggested the response of
the heart rate variability (HRV) as a method to identify
the AT in young healthy individuals [10]. The HRV is a
non-invasive measure of the oscillation between conse-
cutive cardiac cycles (as measured between each R-R
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vasive evaluation of the sympathetic (SNS) and parasym-
pathetic nervous system (PNS) activity both during
resting and low intensity exercise [11].
D u r i n gl o wt om o d e r a t ee x e r c i s ei n t e n s i t yt h eh e a r t
rate (HR) increase is mainly controlled by the PNS with-
drawal [12]. On the other hand, at higher intensities
(e.g. above AT), there is a reduction in the parasympa-
thetic modulation concomitant to an increase in sympa-
thetic activity [13,14] an dt h u sad e c r e a s ei nH R Vi s
observed [15]. Such transition between the increase in
the SNS activity and the vagal tone withdrawal occurs
close to 60% VO2max, being close to the intensity at
which the lactate (LT) and ventilatory (VT) thresholds
have been observed for healthy young individuals
[10,15]. However, the validity of the HRV in estimating
the LT and VT for individuals who may have autonomic
dysfunction associated with T2D [16-18] has not been
previously examined.
The HRV as a measure to estimate the AT is noninva-
sive and inexpensive, providing information regarding
the autonomic regulation during exercise. In spite of
presenting a higher sympathetic activity during resting
and light exercise [19,20] the HRV responses of T2D is
thought to be sensitive to predict the LT and VT nonin-
vasively by considering the intensity at which the vagal
withdrawal occurs. However, the validity of HRV in esti-
mating the LT and VT for individuals with T2D has not
been investigated yet.
Thus, the purposes of present study were 1) to analyze
the possibility of identifying the heart rate variability
threshold (HRVT) by considering the responses of para-
sympathetic indicators during incremental exercise test,
and 2) to compare and verify the relationships between
t h eH R V Tw i t ht h eV Ta n dL Tf o ri n d i v i d u a l sw i t h
(TD2) and without type-2 diabetes (ND).
Methods
Participants
After approval of the local Ethics Committee for Human
Research and obtaining written informed consent of the
volunteers, 9 T2D individuals, being 4 male and 5 female
(55.6 ± 5.7 years, 83.4 ± 23.6 kg, 30.9 ± 5.2 kg.m
2(-1)) and
10 ND, being 8 male and 2 female (50.8 ± 5.1 years, 76.2
± 14.3 kg, 26.5 ± 3.8 kg.m
2(-1)) participated in this study.
Diabetes diagnostic confirmation was conducted through
previous medical screening and laboratory measurements
such as blood glucose and estimates of glycated hemo-
globin (HbA1c) [21]. The individuals with T2D were on
medical and nutritional treatment, using oral hypoglyce-
miants (Sulfonylureas, Metformin, Metformin+Glibencla-
mide, Glimepiride, Pioglitazone Chloridrate)a n d / o r
controlled food intake. Exclusion criteria for participation
in this study included previous diagnosis of peripheral
and autonomic neuropathy, retinopathy, as well as
diabetic foot ulcerations and orthopedic complications,
the use of insulin, and/or use of medicines that would
directly affect the HR, or even any other problem
that would impair the participants’ ability to complete all
the study procedures. The general characteristics of the
volunteers are presented in table 1.
General procedures
All experimental sessions were carried out in the Labora-
tory of Physical Evaluation and Training (LAFIT) of the
Catholic University of Brasília, during the morning per-
iod, 2 h after volunteers had ingested a standardized
breakfast consisting of 315.9 kcal as follows: 53 g (67.1%
- 212 kcal) of carbohydrate; 4.6 g (5.8%- 18.3 kcal) of pro-
tein and 9.5 g (27.1%-85.6 kcal) of fat, which was consid-
ered a moderate glycemic index meal (GI = 73.9). The
participants were submitted to a physician evaluation,
including resting electrocardiogram (ECG) (ELITE,
Micromed
®) and blood pressure (BP) measurements (BP
3AC1-1 Microlife Co.), besides anthropometric measure-
ments and incremental exercise test. During the incre-
mental exercise test, measurements of HR, BP, rate of
perceived exertion (RPE), as well as ventilatory and blood
lactate variables were continuously monitored.
Incremental exercise test and measurements
The incremental test (IT) was performed on an electro-
magnetic cycle ergometer (Lode Excalibur Sport - Nether-
lands) with 15 watts of initial workload and 15 watts
increments at each 3-min stage until volitional exhaus-
tion, maintaining 60 revolutions per minute. The cardiol-
ogist of the laboratory monitored the ECG of the
Table 1 Characteristics of the type 2 diabetics individuals
(T2D) (n = 9) and non diabetics individuals (ND) (n = 10)
T2D ND
Age (years) 55.6 ± 5.7 50.8 ± 5.1
Weight (kg) 83.4 ± 23.6 76.2 ± 14.3
Height (cm) 163.1 ± 10.6 169.0 ± 9.2
BMI (kg.m
2(-1)) 30.9 ± 5.2 26.5 ± 3.8
Time of disease (years) 6.0 ± 2.3 -
Fasting blood glucose (mg.dL
-1) 138.6 ± 34.2* 91.1 ± 5.5
HbA1c (%) 6.8 ± 1.3* 5.2 ± 0,4
VO2peak (mL.kg.
-1.min
-1) 20.6 ± 4.3* 29.4 ± 6.8
RMSSDrest (ms) 21.2 ± 3.5 26.3 ± 5.1
SD1rest (ms) 15.3 ± 2.5 20.9 ± 4.6
Data expressed as mean (± standard deviation) and standard error of mean
for heart rate variability variables (RMSSD and SD1).
BMI = body mass index; VO2peak= peak oxygen uptake; HbA1c= glycated
hemoglobin estimated as suggested Rohlfing et al. [21]; RMSSDrest= square
root of the mean squared successive differences between adjacent R-R
intervals in rest; SD1rest= standard deviation of variability instantaneous beat-
to-beat in rest. *p < 0.05 in relationship to ND group.
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possible abnormality during exercise.
During the pre-exercise resting, as well as during the
last 20 s of each incremental stage, a 25 μLs a m p l eo f
capillarized blood was collected from the ear lobe
trough heparinized and calibrated glass capillaries, being
deposited in microtubes (Eppendorf) containing 50 μLo f
sodium fluoride (NaF) 1% for latter analyses of the [Lac]
through an electroenzimatic method (Yellow Springs
2.700 STAT, OH, USA).
Expired gases were also measured during the IT
through a gas analyzer (Metalyzer 3B, Cortex Biophysik,
Germany) that was previously calibrated with a 3-L syr-
inge (flow calibration) and a standard mixed gas con-
taining 4.9% CO2 and 17% O2 (gas calibration). The
values of ventilation (VE), oxygen uptake (VO2) and car-
bon dioxide production (VCO2)w e r er e c o r d e dd u r i n g
the last 20 s of each 3-min stage.
During the entire IT, the R-R intervals were recorded
(Polar
® S810i, Polar Electo Oy, Kempele, Finland) [22]
and filtered in the Polar Precision Performance (v. 4.0)
software.
Lactate threshold (LT) determination
The blood lactate kinetics during the IT stages identified
the LT, being considered an exercise intensity above
which an over proportional increase in blood lactate was
observed in relation to increasing workload [1].
Ventilatory threshold (VT) and VO2peak determination
Expired gases were collected breath by breath and the
data from the last 20 seconds. The VT was determined
through the analyses of the ventilatory equivalents of O2
(VE/VO2)a n dC O 2 (VE/VCO2), being considered
the intensity corresponding to the moment that VE/
VO2 presented an over proportional increase in relation
to VE/VCO2 [23]. VO2peak was considered as the highest
oxygen consumption attained at the exhaustion moment
[24].
Heart rate variability threshold determination (HRVT)
Initially, the R-R intervals were analyzed by the time
domain through the square root of the mean squared
successive differences between adjacent R-R intervals
(RMSSD). Also, heart rate variability (HRV) was ana-
lyzed through the Poincaré plotting technique, from
which the instantaneous variability of beat to beat data
was derived by means of SD1, according to procedures
previously described [15,25]
The RMSSD and SD1 corresponded to the R-R inter-
val measures of the last 60 s of each 3-min stage during
the IT. All analyses were run through the HRV Analysis
v1.1 software (Biosignal Laboratory, University of Kuo-
pio, Finland).
For the determination of the HRVT, a stabilization
point lower than 3 milliseconds (ms) was adopted for of
the vagal activity indices (SD1 and RMSSD) plotted
against the absolute workload (Figure 1) [11,25,26]
Data Analysis
The data are presented as means (± SD). In order to
compare the characteristics of the groups, the Student-t
test for independent samples was applied. After asses-
sing normality of data through the test of Skewnees and
Kurotsis, comparisons between and within groups were
done by using an ANOVA for repeated measures, with
Figure 1 Determination of the heart rate variability threshold (HRVT-RMSSD and HRVT-SD1), for type 2 diabetes mellitus individuals.
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correlation was used to verify the relationships among
the studied methods to determine AT and the Bland &
Altman technique was applied to verify the agreement
among different methods [11,27]. In addition, we also
applied the kappa index between the methods of identi-
fying the anaerobic threshold. The significance level
adopted was P < 0.05 (Statistica
® version 5.0).
Results
The results presented in table 2 show no significant dif-
ferences among the workloads (W) corresponding to
AT identified by different methods both groups. For
both groups the HR, [Lac], VO2 and RPE corresponding
to the AT identified by different techniques did not dif-
fer from each other (Table 2). Further, for the T2D
group significant correlations (p < 0.01) between LT and
peak power (Wpeak) (r = 0.89), VT and Wpeak (r = 0.75),
HRVT-RMSSD and Wpeak (r = 0.80) and between
HRVT-SD1 and Wpeak (r = 0.80) were observed. High
correlations (p < 0.001) were also found in the ND
group for the LT and Wpeak (r = 0.95), VT and Wpeak (r
= 0.92) and HRVT-RMSSD and Wpeak (r = 0.89) and
between HRVT-SD1 (r = 0.90). The relationship among
exercise intensities (W) corresponding to the studied
thresholds are presented in table 3 for both groups.
The Bland and Altman plots showed good agreement
for the VO2 corresponding to LT, VT, HRVT-RMSSD
and HRVT-SD1 based on the low bias and relatively
narrow limits of agreement [Bias (± 95% of confidence
interval)] presented in both groups (T2D and ND)
(Table 4 and Figure 2). In addition, the Kappa index
also evidenced a good to excellent agreement among
studied parameters for both T2D (K = 0.66 to K = 0.92)
and ND (K = 0.62 to K = 0.92).
Discussion
The ability of the HRV responses in estimating LT and
VT was investigated in individuals with T2D and ND.
The findings confirmed our hypothesis that AT could
be identified in T2D through the parasympathetic mar-
kers of the HRV responses similarly to ND, being not
different and highly correlated to the LT and VT for
both groups (Tables 2 and 3, Figure 2). The HRV pre-
diction of AT through autonomic variables such as
RMSSD and SD1 has been studied in different popula-
tions [10,15,28,29]. However, this is the first study in
which the AT was identified through HRV responses in
T2D, in spite of the fact that this disease is associated
with autonomic dysfunction [30,31].
The technique of HRV, as used in the present study,
considered a progressive reduction of RMSSD and SD1
to intervals lower than 3 ms as markers of AT intensity
as proposed by others [10,26]. Lima and Kiss [26] found
a high relationship between workloads (Watts) corre-
sponding to HRVT and LT for healthy subjects (r =
0.76). In this study, even higher correlations were
observed between LT and RMSSD threshold (r = 0.85
and r = 0.94) and between LT and SD1 threshold (r =
0.87 and r = 0.96) for T2D and ND groups, respectively.
The main findings of present study evidenced the
HRV as an effective parameter for exercise evaluation in
individuals with T2D, due to its noninvasive characteris-
tic as well as because it evaluates variables associated
with autonomic function. According to Yeckel et al. [30]
the autonomic dysfunction usually precedes the occur-
rence of T2D. In addition, an elevated sympathetic
activity is associated to a higher risk for cardiovascular
events such as infarction and stroke [32,33]. The HRVT
seems to identify an exercise intensity that represents
the transition from a lower to a higher sympathetic
Table 2 Mean (± SD) of workload, blood lactate, heart rate and the rate of perceived exertion corresponding to the
lactate (LT), ventilatory (VT) and heart rate variability thresholds (HRVT-RMSSD and HRVT-SD1)
Parameter Worload (W) VO2 (mL.kg.
-1min
-1) [LAC] (mmol.L
-1) HR (bpm) RPE (score)
T2D LT 55.0 ± 26.0 13.0 ± 1.2 2.9 ± 0.6 126.4 ± 14.1 13.0 ± 2.1
LV 58.3 ± 23.0 13.3 ± 1.8 3.0 ± 1.0 128.8 ± 14.4 13.2 ± 2.0
HRVT-RMSSD 58.3 ± 17.5 13.3 ± 1.1 3.0 ± 0.7 128.2 ± 8.9 13.6 ± 1.4
HRVT-SD1 50.0 ± 15.0 13.0 ± 2.1 2.8 ± 0.9 123.2 ± 6.9 12.9 ± 1.8
Exhaustion 96.7 ± 33.6‡ 20.6 ± 4.6‡ 6.5 ± 2.5‡ 159.7 ± 20.8‡ 18.4 ± 1.6‡
ND LT 85.5 ± 33.2* 19.2 ± 5.9* 3.6 ± 0.6* 139.3 ± 17.4 14.3 ± 1.4
LV 91.5 ± 28.7* 20.3 ± 5.6* 4.1 ± 1.1* 143.1 ± 16.2 14.6 ± 1.2
HRVT-RMSSD 85.5 ± 34.7* 19.0 ± 5.3* 3.5 ± 0.7 137.7 ± 13.1 13.9 ± 1.2
HRVT-SD1 82.5 ± 34.1* 18.6 ± 5.3* 3.2 ± 0.7 131.2 ± 13.8 13.7 ± 1.2
Exhaustion 135.0 ± 45.3‡ 29.4 ± 6.8‡ 7,7 ± 2.0‡ 173.6 ± 9.3‡ 18.8 ± 1.3‡
Exhaustion in T2D (n = 9) and ND (n = 10).
T2D = individuals with type 2 diabetes; ND = individuals without type-2 diabetes; *p < 0.05 in relation to corresponding results for T2D; ‡ p < 0.05 in relation to
the thresholds (LT, TV, HRVT RMSSD and HRVT-SD1). No differences were observed within groups for the methods to identify anaerobic threshold intensities.
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occurrence of cardiovascular events T2D individuals.
Therefore, the identification of the HRVT intensity may
be a safe and useful procedure for exercise evaluation
and prescription.
Another benefit of HRVT identification is the avoid-
ance of elevated financial costs usually associated with
invasive methods. Exercise tests involving blood collec-
tion and biochemical measures, and/or the use of
expensive apparatus for expired gases analysis, as well as
trained professionals dealing with such protocols are
expensive and thus of difficult access to a major part of
the population.
It has been suggested that vagal withdraw progres-
sively occurs during IT, and is almost completely inhib-
ited at intensities around 50-60% VO2max [16,29]. For
the T2D participants of the present investigation, the
vagal withdrawal, as observed by the RMSSD and SD1
stabilization, occurred at intensities corresponding to
64.8% and 66.6% of VO2peak, respectively. Previous stu-
dies with T2D also verified similar results regarding LT
occurring at intensities around 66% VO2peak [4,34,35]
what, in turn, may be of practical application.
The fact that participants of the present study had
their HRVT being reached at 64.2 to 66.6% VO2peak
may be at least partially explained by their low physical
fitness (VO2peak of 20.6 ± 4.3 mL.kg
-1.min
-1 for T2D
and 29.4 ± 6.8 mL.kg
-1.min
-1 for ND). This finding was
also observed in a previous study comparing sedentary
T2D individuals to physically active T2D and ND coun-
ter partners [35]. Moreira et al. also observed a trend
towards lower [Lac] during the IT for T2D group, sug-
gesting lower motor units recruitment and thus lower
anaerobic glycolytic activity, lower power output, blood
lactate and VO2 at the exhaustion moment as compared
to ND, similar to what happened in present study [34].
The RPE may also be an interesting noninvasive tool
for exercise evaluation and prescription for both T2D
and ND. The RPE integrates cardiovascular, respiratory,
neuromuscular and metabolic inputs as a result of
increasing exercise intensity [36]. Some studies have
demonstrated that during incremental exercise test, RPE
scores around 12-13, as measured through the 15-point
Borg scale, is related to attainment of the AT [2,9]. It
was observed that RPE scores corresponding to AT in
present study were around 12.9 ± 1.8 to 13.6 ± 1.4 for
T2D, and 13.7 ± 1.2 to 14.6 ± 1.2 for ND (Table 2). The
use of RPE for controlling exercise intensities may be an
useful tool to ensure exercise prescription for T2D, once
the RPE of 12-14 may help to delimitate the transition
of moderate exercise to exercise intensities which elicit-
ing blood glucose to increase [2,8,37,38].
One of the limitations of present study was that the
maximal lactate steady state (MLSS) intensity was not
determined for comparison to the studied protocols.
The MLSS determination is considered the gold stan-
dard method among those of exercise evaluation
through blood lactate response to exercise. Denadai
et al. [39] and Van Schuylenbergh et al. [40] have shown
this parameter to be highly correlated and not different
to the LT and VT intensities. So we may suggest that
Table 3 Relationship among intensities (W)
corresponding to the studied thresholds for T2D (n = 9)
and ND (n = 10)
LT (W) VT (W) HRVT-RMSSD (W)
T2D VT (W) 0.83* - -
HRVT-RMSSD(W) 0.85* 0.83* -
HRVT-SD1 (W) 0.87* 0.76* 0.68*
ND VT (W) 0.95* - -
HRVT-RMSSD (W) 0.94* 0.91* -
HRVT-SD1 (W) 0.96* 0.93* 0.98*
T2D = Type 2 diabetes mellitus individuals; ND = non diabetics individuals;
LT = Lactate threshold; VT = ventilatory threshold; HRVT-RMSSD = heart rate
variability threshold for RMSSD; HRVT-SD1 = heart rate variability threshold for
SD1. *significant correlation p < 0.01.
Table 4 Agreement between VO2 corresponding to LT, VT and HRVT-RMSSD and HRVT-SD1 for type 2 diabetes
mellitus individuals (n = 9) and non diabetes individuals (n = 10)
Groups Reference methods Testing methods Mean of differences Limits of Agreement
T2D LT HRVT-RMSSD 0.3 ± 2.0
LT HRVT-SD1 0.1 ± 4.6
VT HRVT-RMSSD 0.1 ± 4.1
VT HRVT-SD1 0.5 ± 4.9
ND LT HRVT-RMSSD -0.3 ± 4.2
LT HRVT-SD1 0.3 ± 2.9
VT HRVT-RMSSD 1.3 ± 5.9
VT HRVT-SD1 0.9 ± 6.2
T2D = Type 2 diabetes individuals; ND = non diabetes individuals; LT = lactate threshold; VT = ventilatory threshold; HRVT-RMSSD = Heart rate variability
threshold for RMSSD; HRVT-SD1 = Heart rate variability threshold for SD1.
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determinations), which did not differ from HRVT,
would also represent the MLSS intensity.
Several investigations have shown a relationship between
t h ee x e r c i s ei n t e n s i t ya tw h i c ht h ev a g a lw i t h d r a w ni s
observed with those corresponding to VT [15,41] and LT
[10,26]. In the present study the HRVT, as identified
through the quantitative analyses of the Poincaré plots
(SD1), occurred at exercise intensities not different to the
LT and VT. On the other hand, in spite of non-detectable
statistical differences, the exercise intensities associated to
the occurrence of the HRVT-SD1 trend to be slightly
lower than LT and VT for both T2D and ND, but without
statistical difference (p > 0.05). Similarly to our findings,
A
B
C D
E
F
G
H
Figure 2 Agreement between VO2 corresponding to LT, VT and HRVT-RMSSD and HRVT-SD1 for type 2 diabetes mellitus individuals
(2 A, B, C, D) and non diabetes individuals (2 E, F, G, H).
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HRVT was lower than VT, and the authors suggested that
vagal withdrawal would precede the VT occurrence during
IT. It is expected that mechanisms responsible for home-
ostasis during exercise may be related to the occurrence of
both VT and LT, and is also dependent to the sympa-
thetic/parasympathetic balance. Thus, it is reasonable that
the HRVT occurs at exercise intensities closely related to
LT and VT intensities. Thus, once the HRVT identified by
the RMSSD seemed to better predicts the LT and VT as
evidenced by the Bland and Altman analysis, we may sug-
g e s tt h a tR M S S Dm a yb eam o r ea c c u r a t ev a r i a b l ea n d
thus should be preferred in relation to SD1.
In conclusion it was possible to identify the HRVT
from autonomic indices (RMSSD and SD1) for both
T2D and ND, with no differences in relation to LT and
VT. Furthermore, high correlations and good agreement
between the examined methods were observed, suggest-
ing the validity of HRVT even for T2D. Additional stu-
dies are necessary to investigate the reproducibility and
sensitivity of AT as identified by HRV measures to var-
ious interventions, including physical training.
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